# DIM for prostate?

https://curology.com/blog/the-truth-about-using-dim-supplements-for-hormonal-acne-do-they-work/

## Prostate cancer - limited effectiveness?
> One patient without AH at 225 mg experienced a 50% PSA decline. One patient with BR-DIM dose of 225 mg had PSA stabilization. The other 10 patients had an initial deceleration of their PSA rise (decrease in slope), but eventually progressed based on continual PSA rise or evidence of metastatic disease.

Heath, Elisabeth I et al. “A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer.” American journal of translational research vol. 2,4 402-11. 23 Jul. 2010

## prostatic intraepithelial neoplasia
> The intermediate results of the 21 patients in this multicenter, randomized, placebo-controlled, double-blind study show that Infemin may be a promising drug candidate in patients with  high-grade PIN.

Paltsev, Mikhail et al. “First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN).” The EPMA journal vol. 7,1 5. 2 Apr. 2016, doi:10.1186/s13167-016-0057-3

---

## Cervical dysplasia
> There was no statistically significant difference in any outcome between the DIM and placebo group.

Del Priore, Giuseppe et al. “Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia.” Gynecologic oncology vol. 116,3 (2010): 464-7. doi:10.1016/j.ygyno.2009.10.060
